December 18, 2018 Dataset Open Access

Bastiaens, Guido; Tiono, Alfred B.; Okebe, Joseph; Pett, Helmi; Coulibaly, Sam A.; Gonçalves, Bronner P.; Affara, Muna; Ouédraogo, Alphonse; Bougouma, Edith C.; Sanou, Guillaume S.; Nébié, Issa; Bradley, John; Lanke, Kjerstin H. W.; Niemi, Mikko; Sirima, Sodiomon B.; d'Alessandro, Umberto; Bousema, Teun; Drakeley, Chris; Bastiaens, Guido J. H.; Pett, Helmi E.; d'Alessandro, Umberto

BibTeX Export

@dataset{bastiaens_guido_2018_4988492,
  author       = {Bastiaens, Guido and
                  Tiono, Alfred B. and
                  Okebe, Joseph and
                  Pett, Helmi and
                  Coulibaly, Sam A. and
                  Gonçalves, Bronner P. and
                  Affara, Muna and
                  Ouédraogo, Alphonse and
                  Bougouma, Edith C. and
                  Sanou, Guillaume S. and
                  Nébié, Issa and
                  Bradley, John and
                  Lanke, Kjerstin H. W. and
                  Niemi, Mikko and
                  Sirima, Sodiomon B. and
                  d'Alessandro, Umberto and
                  Bousema, Teun and
                  Drakeley, Chris and
                  Bastiaens, Guido J. H. and
                  Pett, Helmi E. and
                  d'Alessandro, Umberto},
  title        = {{Data from: Safety of single low-dose primaquine in 
                   glucose-6-phosphate dehydrogenase deficient
                   falciparum-infected African males: two open-label,
                   randomized, safety trials}},
  month        = dec,
  year         = 2018,
  note         = {{<div class="o-metadata\_\_file-usage-entry">SAFEPRIM 
                   Burkina Faso Adverse Events<div class="o
                   -metadata\_\_file-description">Adverse events
                   SAFEPRIM trial Burkina Faso</div><div class="o
                   -metadata\_\_file-name">DRYAD\_SAFEPRIM Burkina Faso
                   Adverse Events.xlsx<br></div></div><div class="o
                   -metadata\_\_file-usage-entry">SAFEPRIM Gambia
                   Adverse Events<div class="o-metadata\_\_file-
                   description">Adverse events SAFEPRIM trial The
                   Gambia</div><div class="o-metadata\_\_file-
                   name">DRYAD\_SAFEPRIM Gambia Adverse
                   Events.xlsx<br></div></div><div class="o
                   -metadata\_\_file-usage-entry">DRYAD SAFEPRIM main
                   dataset Burkina Faso<div class="o-metadata\_\_file-
                   description">Laboratory results from clinical
                   trial in Burkina Faso. Data include haemoglobin
                   concentration, reticulocyte counts, full
                   haematology and biochemistry.</div><div class="o
                   -metadata\_\_file-name"></div></div><div class="o
                   -metadata\_\_file-usage-entry">DRYAD SAFEPRIM main
                   dataset The Gambia<div class="o-metadata\_\_file-
                   description">Laboratory results from clinical
                   trial in The Gambia. Data include haemoglobin
                   concentration, reticulocyte counts, full
                   haematology and biochemistry.</div><div class="o
                   -metadata\_\_file-name"></div></div><p>Funding
                   provided by: National Science
                   Foundation<br>Crossref Funder Registry ID:
                   http://dx.doi.org/10.13039/100000001<br>Award
                   Number: BMGF OPP1034789</p>}},
  publisher    = {Zenodo},
  doi          = {10.5061/dryad.230ps},
  url          = {https://doi.org/10.5061/dryad.230ps}
}